Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells

The RIG-I-like receptors RIG-I, LGP2, and MDA5 initiate an antiviral response that includes production of type I interferons (IFNs). The nature of the RNAs that trigger MDA5 activation in infected cells remains unclear. Here, we purify and characterise LGP2/RNA complexes from cells infected with enc...

Full description

Bibliographic Details
Main Authors: Safia Deddouche, Delphine Goubau, Jan Rehwinkel, Probir Chakravarty, Sharmin Begum, Pierre V Maillard, Annabel Borg, Nik Matthews, Qian Feng, Frank J M van Kuppeveld, Caetano Reis e Sousa
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2014-02-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/01535
id doaj-663aa2a635a647259cca6a484c5c450c
record_format Article
spelling doaj-663aa2a635a647259cca6a484c5c450c2021-05-04T23:00:15ZengeLife Sciences Publications LtdeLife2050-084X2014-02-01310.7554/eLife.01535Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cellsSafia Deddouche0Delphine Goubau1Jan Rehwinkel2Probir Chakravarty3Sharmin Begum4Pierre V Maillard5Annabel Borg6Nik Matthews7Qian Feng8Frank J M van Kuppeveld9Caetano Reis e Sousa10Immunobiology Laboratory, Cancer Research UK, London Research Institute, London, United KingdomImmunobiology Laboratory, Cancer Research UK, London Research Institute, London, United KingdomImmunobiology Laboratory, Cancer Research UK, London Research Institute, London, United KingdomBioinformatics Laboratory, Cancer Research UK, London Research Institute, London, United KingdomClonal Sequencing Laboratory, Cancer Research UK, London Research Institute, London, United KingdomImmunobiology Laboratory, Cancer Research UK, London Research Institute, London, United KingdomProtein Purification Laboratory, Cancer Research UK, London Research Institute, London, United KingdomClonal Sequencing Laboratory, Cancer Research UK, London Research Institute, London, United KingdomVirology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, NetherlandsVirology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, NetherlandsImmunobiology Laboratory, Cancer Research UK, London Research Institute, London, United KingdomThe RIG-I-like receptors RIG-I, LGP2, and MDA5 initiate an antiviral response that includes production of type I interferons (IFNs). The nature of the RNAs that trigger MDA5 activation in infected cells remains unclear. Here, we purify and characterise LGP2/RNA complexes from cells infected with encephalomyocarditis virus (EMCV), a picornavirus detected by MDA5 and LGP2 but not RIG-I. We show that those complexes contain RNA that is highly enriched for MDA5-stimulatory activity and for a specific sequence corresponding to the L region of the EMCV antisense RNA. Synthesis of this sequence by in vitro transcription is sufficient to generate an MDA5 stimulatory RNA. Conversely, genomic deletion of the L region in EMCV generates viruses that are less potent at stimulating MDA5-dependent IFN production. Thus, the L region antisense RNA of EMCV is a key determinant of innate immunity to the virus and represents an RNA that activates MDA5 in virally-infected cells.https://elifesciences.org/articles/01535RIG-I-like receptorMDA5LGP2picornavirusEMCVantiviral immunity
collection DOAJ
language English
format Article
sources DOAJ
author Safia Deddouche
Delphine Goubau
Jan Rehwinkel
Probir Chakravarty
Sharmin Begum
Pierre V Maillard
Annabel Borg
Nik Matthews
Qian Feng
Frank J M van Kuppeveld
Caetano Reis e Sousa
spellingShingle Safia Deddouche
Delphine Goubau
Jan Rehwinkel
Probir Chakravarty
Sharmin Begum
Pierre V Maillard
Annabel Borg
Nik Matthews
Qian Feng
Frank J M van Kuppeveld
Caetano Reis e Sousa
Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells
eLife
RIG-I-like receptor
MDA5
LGP2
picornavirus
EMCV
antiviral immunity
author_facet Safia Deddouche
Delphine Goubau
Jan Rehwinkel
Probir Chakravarty
Sharmin Begum
Pierre V Maillard
Annabel Borg
Nik Matthews
Qian Feng
Frank J M van Kuppeveld
Caetano Reis e Sousa
author_sort Safia Deddouche
title Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells
title_short Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells
title_full Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells
title_fullStr Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells
title_full_unstemmed Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells
title_sort identification of an lgp2-associated mda5 agonist in picornavirus-infected cells
publisher eLife Sciences Publications Ltd
series eLife
issn 2050-084X
publishDate 2014-02-01
description The RIG-I-like receptors RIG-I, LGP2, and MDA5 initiate an antiviral response that includes production of type I interferons (IFNs). The nature of the RNAs that trigger MDA5 activation in infected cells remains unclear. Here, we purify and characterise LGP2/RNA complexes from cells infected with encephalomyocarditis virus (EMCV), a picornavirus detected by MDA5 and LGP2 but not RIG-I. We show that those complexes contain RNA that is highly enriched for MDA5-stimulatory activity and for a specific sequence corresponding to the L region of the EMCV antisense RNA. Synthesis of this sequence by in vitro transcription is sufficient to generate an MDA5 stimulatory RNA. Conversely, genomic deletion of the L region in EMCV generates viruses that are less potent at stimulating MDA5-dependent IFN production. Thus, the L region antisense RNA of EMCV is a key determinant of innate immunity to the virus and represents an RNA that activates MDA5 in virally-infected cells.
topic RIG-I-like receptor
MDA5
LGP2
picornavirus
EMCV
antiviral immunity
url https://elifesciences.org/articles/01535
work_keys_str_mv AT safiadeddouche identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT delphinegoubau identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT janrehwinkel identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT probirchakravarty identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT sharminbegum identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT pierrevmaillard identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT annabelborg identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT nikmatthews identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT qianfeng identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT frankjmvankuppeveld identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
AT caetanoreisesousa identificationofanlgp2associatedmda5agonistinpicornavirusinfectedcells
_version_ 1721477211748302848